Norges Bank Rocket Pharmaceuticals, Inc. Transaction History

Norges Bank

$716 Trillion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$20.66 - $26.72 $717,976 - $928,573	34,752 New	34,752 $748,000
Q4 2023 Feb 09, 2024	BUY	$16.78 - $31.94 $4.08 Million - $7.77 Million	243,351 New	243,351 $7.29 Million
Q3 2023 Nov 13, 2024	BUY	$15.07 - $24.05 $3.67 Million - $5.85 Million	243,351 New	243,351 $4.99 Million
Q3 2023 Nov 13, 2023	SELL	$15.07 - $24.05 $4.83 Million - $7.71 Million	-320,773 Closed	0 $0
Q2 2023 Aug 14, 2024	BUY	$16.59 - $23.6 $3.46 Million - $4.92 Million	208,599 Added 600.25%	243,351 $4.84 Million
Q2 2023 Aug 14, 2023	SELL	$16.59 - $23.6 $5.32 Million - $7.57 Million	-320,773 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$15.79 - $22.6 $3.84 Million - $5.5 Million	243,351 New	243,351 $4.17 Million
Q4 2022 Feb 14, 2023	BUY	$15.5 - $22.76 $4.97 Million - $7.3 Million	320,773 New	320,773 $6.28 Million
Q3 2022 Nov 13, 2023	BUY	$12.37 - $18.41 $3.97 Million - $5.91 Million	320,773 New	320,773 $5.12 Million
Q2 2022 Aug 14, 2023	BUY	$7.96 - $16.64 $2.55 Million - $5.34 Million	320,773 New	320,773 $4.41 Million
Q1 2022 May 12, 2023	BUY	$13.16 - $23.68 $102,648 - $184,704	7,800 Added 2.43%	328,573 $5.21 Million
Q1 2022 May 09, 2022	SELL	$13.16 - $23.68 $6.35 Million - $11.4 Million	-482,779 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$21.52 - $36.02 $10.4 Million - $17.4 Million	482,779 New	482,779 $10.5 Million
Q3 2021 Nov 14, 2022	BUY	$27.42 - $48.97 $9.09 Million - $16.2 Million	331,679 New	331,679 $9.91 Million
Q3 2021 Nov 05, 2021	SELL	$27.42 - $48.97 $9.36 Million - $16.7 Million	-341,312 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$39.41 - $47.25 $13.5 Million - $16.1 Million	341,312 New	341,312 $15.1 Million
Q2 2021 Aug 10, 2021	SELL	$39.41 - $47.25 $12.9 Million - $15.5 Million	-328,010 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$43.34 - $65.91 $14.2 Million - $21.6 Million	328,010 New	328,010 $14.6 Million
Q1 2021 May 07, 2021	SELL	$43.34 - $65.91 $1.08 Million - $1.65 Million	-25,000 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$23.3 - $59.57 $582,500 - $1.49 Million	25,000 New	25,000 $1.37 Million

Others Institutions Holding RCKT

# of Institutions

210

Shares Held

93.3M

Call Options Held

319K

Put Options Held

70.3K

Rtw Investments, LP New York, NY

17.7M
Shares

$182 Million
5.21% of portfolio
Wellington Management Group LLP Boston, MA

11.2M
Shares

$116 Million
0.04% of portfolio
Black Rock Inc. New York, NY

6.19M
Shares

$63.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.54M
Shares

$57.1 Million
0.0% of portfolio
Westfield Capital Management CO LP Boston, MA

4.49M
Shares

$46.3 Million
0.39% of portfolio

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $780M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account